RA
Rajeev Aggarwal
About Rajeev Aggarwal
Data last updated:
Rajeev Aggarwal is a Managing Director at Casca Remedies Pvt Ltd (since 1988) and Managing Director at Divus Laboratories Limited (since 2003). The companies operate in FMCG and Chemicals and Materials. The largest current company by reported revenue is Casca Remedies Pvt Ltd at ₹26.56 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 24 Feb 1988 | 1988 | ₹26.56 Cr (FY 2025) | Active | |
| Managing Director | 06 Aug 2003 | 2003 | Active |
Board colleagues of Rajeev Aggarwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ishaan Aggarwal | 06820089 | Casca Remedies Pvt Ltd | Director |
| Arunkumar Chamanlal Mittal | 02165710 | Divus Laboratories Limited | Director Appointed In Casual Vacancy |
| Bharat Bhushan Aggarwal | 01227044 | Divus Laboratories Limited | Director |
| Raman Aggarwal | 08463458 | Divus Laboratories Limited | Director Appointed In Casual Vacancy |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajeev Aggarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajeev Aggarwal
Rajeev Aggarwal currently holds 2 directorships: Casca Remedies Pvt Ltd (Managing Director, since 24 Feb 1988, revenue ₹26.56 Cr (FY 2025)); Divus Laboratories Limited (Managing Director, since 06 Aug 2003).
Rajeev Aggarwal was first appointed on 24 Feb 1988 as Managing Director at Casca Remedies Pvt Ltd. The most recent appointment on record is 06 Aug 2003 at Divus Laboratories Limited.
The current boards of Rajeev Aggarwal's companies include Ishaan Aggarwal (Casca Remedies Pvt Ltd), Arunkumar Chamanlal Mittal (Divus Laboratories Limited), Bharat Bhushan Aggarwal (Divus Laboratories Limited), Raman Aggarwal (Divus Laboratories Limited).